Delivery Order SPE2DE24DA017-SPE2D624F2SSZ
- Not listed
- This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The $5,255.58 fixed-price delivery order contract is for the supply of 1.7 million units of TIGERLINK SUTURETAPE, a specialized medical product, with a completion date of July 18, 2025. Arthrex, a for-profit Subchapter S Corporation, has a strong track record of providing innovative orthopedic solutions to government...
- This firm-fixed-price delivery order was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $1,987.48 contract is for the delivery of 4565615748 SUTURETAPE FIBERLINK 1.3MM WH/BL, with a period of performance through September 3, 2024. Arthrex, a for-profit Subchapter S Corporation headquartered in Naples, Florida, has secured numerous federal contracts with agencies like...
- This is a $2,119.57 fixed-price delivery order awarded by the Medical Supply Chain division of the Department of Defense to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract is for the supply of TIGERTAPE CERCLAGE W/O NEEDLE, a specialized orthopedic product, with a completion date of September 10, 2024. Arthrex is a for-profit Subchapter S Corporation headquartered in Naples, Florida. This contract does not have a set-aside designation,...
- This is a federal contract award from the Defense agency Medical Supply Chain (97AS) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The award, valued at $1,719.60, is a Delivery Order contract for the supply of SUTURETAPE 1.3MM WH/BL & WH/BLK. The contract has a fixed price with economic price adjustment pricing type and an ultimate completion date of August 7, 2024. Arthrex Inc. is a for-profit Subchapter S Corporation headquartered in Naples,...
- This federal contract award, valued at $3,615.48, was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract is a Delivery Order for 'SUTURETAPE TIGERLOOP W/ NDL WH/BLK' medical supplies, with a period of performance ending on March 13, 2025. Arthrex Inc. is a for-profit Subchapter S Corporation based in Naples, Florida, that specializes in developing, manufacturing, and supplying advanced...
- This federal contract award, SPE2DH19D7001|SPE2D424F947Z, was issued by the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $8,400.67 fixed-price with economic price adjustment contract is for the delivery of TIGERLINK SUTURETAPE 0.9MM WH/BLK medical supplies. The contract has a performance period ending on July 19, 2024 and does not have a set-aside designation. Arthrex Inc. is a for-profit Subchapter S Corporation...
- This federal contract award was issued by the Department of Defense's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $6,112.26, is for the delivery of SUTURETAPE FIBERLINK 1.3MM WH/BL medical supplies. The contract has a fixed price with economic price adjustment pricing type and runs until January 14, 2025. Arthrex, a for-profit Subchapter S Corporation, holds a significant Indefinite Delivery Contract...
- This is a federal contract award from the Defense Logistics Agency's (DLA) Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $1,124.64, is for the delivery of SUTURETAPE FIBERLINK 1.3MM WH/BL medical supplies. The contract type is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing structure, and the ultimate completion date is December 2, 2024. Arthrex Inc. is a for-profit Subchapter S...
- This federal contract award was issued by the Medical Supply Chain division of the Department of Defense to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $4,445.30, is a Delivery Order for the procurement of SUTURELASSO, 25 DEGREE TIGHT CURVE RIGHT surgical devices. The contract has a fixed price with economic price adjustment and a completion date of September 20, 2024. Arthrex, a for-profit Subchapter S Corporation based in...
- This is a federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies, by the Defense Logistics Agency's Medical Supply Chain. The contract is a Delivery Order valued at $1,302.84 for the supply of SUTURETAPE FIBERLINK 1.3MM WH/BL medical products. The contract has a fixed-price with economic price adjustment pricing type and an ultimate completion date of May 20, 2025. Arthrex is a for-profit Subchapter S Corporation based in Naples, Florida,...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D624F2SSZDelivery Order
This is a federal contract award from the Department of Defense's Medical Supply Chain agency to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The award, valued at $4,224.00, is for the delivery of 4565910092 TIGERLINK SUTURETAPE 0.9MM WH/BLK surgical supplies. The contract has a fixed price with economic price adjustment pricing type and a completion date of September 26, 2024. Arthrex, a for-profit Subchapter S Corporation headquartered in Naples, Florida, has received numerous federal contract awards from agencies such as the Department of Veterans Affairs (VA) and Department of Defense (DoD) for its innovative orthopedic technologies, including surgical implants, instruments, and biologics. This specific award does not have a set-aside designation, indicating Arthrex's competitive position in the open market for federal contracts. Additionally, Arthrex holds a larger Indefinite Delivery Contract (IDC) with the VA valued at $471,048,172.66, which allows VA medical centers nationwide to acquire the company's orthopedic products on an as-needed basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 9/23/24 |